1-(4-thio-beta-D-ribofuranosyl)uracil
Modify Date: 2024-01-05 08:52:09
1-(4-thio-beta-D-ribofuranosyl)uracil structure
|
Common Name | 1-(4-thio-beta-D-ribofuranosyl)uracil | ||
|---|---|---|---|---|
| CAS Number | 6741-73-7 | Molecular Weight | 260.27 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C9H12N2O5S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of 1-(4-thio-beta-D-ribofuranosyl)uracil4′-Thiouridine (1-(4-thio-beta-D-ribofuranosyl)uracil) is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | 1-(4-thio-β-D-ribofuranosyl)uracil |
|---|---|
| Synonym | More Synonyms |
| Description | 4′-Thiouridine (1-(4-thio-beta-D-ribofuranosyl)uracil) is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C9H12N2O5S |
|---|---|
| Molecular Weight | 260.27 |
| Exact Mass | 260.04700 |
| PSA | 140.85000 |
| 1-<4-Thio-α-ribofuranosyl>-uracil |
| 1-(4-thio-β-d-ribofuranosyl)uracil |
| 1-(4-thio-β-D-ribofuransoyl)uracil |
| 1-((2R,3R,4S,5R)-3,4-Dihydroxy-5-hydroxymethyl-tetrahydro-thiophen-2-yl)-1H-pyrimidine-2,4-dione |
| 4'-thio-uridine |